American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws—2009 Update
Top Cited Papers
- 31 May 2009
- journal article
- Published by Elsevier BV in Journal of Oral and Maxillofacial Surgery
- Vol. 67 (5), 2-12
- https://doi.org/10.1016/j.joms.2009.01.009
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous BisphosphonatesJournal of Bone and Mineral Research, 2008
- Zoledronate, Smoking, and Obesity Are Strong Risk Factors for Osteonecrosis of the Jaw: A Case-Control StudyJournal of Oral and Maxillofacial Surgery, 2008
- A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patientsAnnals of Oncology, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisThe New England Journal of Medicine, 2007
- Jaw osteonecrosis associated with bisphosphonates: Multiple exposed areas and its relationship to teeth extractions. Study of 20 casesOral Oncology, 2006
- Osteonecrosis of the Jaw in Multiple Myeloma Patients: Clinical Features and Risk FactorsJournal of Clinical Oncology, 2006
- Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapyOral Diseases, 2005
- Alendronate improves bone mineral density in primary biliary cirrhosis: A randomized placebo-controlled trialJournal of Hepatology, 2005
- Osteonecrosis of the Jaw and BisphosphonatesThe New England Journal of Medicine, 2005
- Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal WomenThe New England Journal of Medicine, 2004